Evidence map›Paper›PMID 41751313›Full record

ReviewBiomedicines2026

Exosomes: Roles and Therapeutic Potential in Pain.

Yuting Wen, Rui Zhang, Jitong Wang, Zhouyun Ma, Changsheng Dong, Ruixiang Li, Jiange Zhang

Abstract readReview
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuting WenInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Rui ZhangInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jitong WangInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhouyun MaInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Changsheng DongCancer Institute of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0000-0001-8385-7904
Ruixiang LiInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jiange ZhangInnovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Funding

the Expenditure Budget Program of Shanghai University of Traditional Chinese Medicine 23KFL001the National Natural Science Foundation of China 82003800the New Interdisciplinary Subject Funding Program for Shanghai Traditional Chinese Medicine E2-F18003the Open Project of National Major Scientific and Technological Infrastructure for Translational Medicine TMSK-2021-405the Science and Technology Commission of Shanghai Municipality 20ZR1473200the Shanghai Municipal Education Commission 2019-01-07-00-10-E00072the Shanghai Municipal Health Commission/Shanghai Municipal Administration of Traditional Chinese Medicine ZY (2021-2023)-0501the Shanghai Pujiang Programme 23PJD085the Shanghai Science and Technology Development Fund from Central Leading Local Govern-ment YDZX20223100001004the State Administration of Traditional Chinese Medicine of Peoples Republic of China GZYYGJ2019059
6 · The paper itself

Abstract

Pain is a signal that the human body is being damaged or attacked by disease. It significantly impacts quality of life and imposes a substantial economic burden. Current analgesic drugs fail to meet clinical application standards due to limited choice, inadequate efficacy, and side effects. Consequently, the development of new treatment strategies for pain relief is essential. Pain signals are conveyed by nociceptors via the central nervous system to the brain, with cell-to-cell communication serving as a crucial step in the sensory nociceptive process. Exosomes are extracellular vesicles involved in intercellular communication, capable of transporting and delivering biological macromolecules. Growing evidence suggests that exosomes contribute significantly to the pathological processes associated with pain-related diseases. Summarizing the characteristics of exosomes and their molecular cargo under various pain conditions, along with identifying specific exosomal signatures, is essential for the early diagnosis and treatment of such diseases. This review systematically elucidates the molecular and cellular mechanisms of exosomes in pain relief and evaluates their potential therapeutic value in pain management. We aim to deepen the understanding of exosome-pain interactions, thereby laying the foundation for developing novel and promising therapeutic strategies. Furthermore, we scrutinize the current status of clinical research on exosome-mediated analgesia and dissect the prevailing technical challenges and future research directions. Our objective is to provide clear scientific guidance and a theoretical basis to facilitate the clinical translation of exosome therapies.

Indexed as

cancer paindrug deliveryexosomesinflammatory painneuropathic pain

Identifiers

PMID41751313
PMCPMC12937818

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.